胎盘生长因子缺乏会引发肥胖和衰老相关的代谢综合征
Ji Hee Lim1, Yaeni Kim2, Min Young Kim1
1Division of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Metabolism: clinical and experimental
|August 22, 2024
概括
胎盘生长因子 (PlGF) 对代谢健康至关重要. 低的plgf水平通过损害血管生长和功能,导致代谢综合征 (ms),但plgf治疗显示出有前途.
科学领域:
- 内分泌学和新陈代谢学
- 血管生物学 血管生物学
- 分子生物学分子生物学
背景情况:
- 脂肪组织中肥胖诱导的不充分的血管生成有助于炎症和胰岛素抵抗.
- 代谢综合征 (MS) 是一种复杂的疾病,与血管功能受损和代谢失调有关.
- 胎盘生长因子 (PlGF) 在MS的发病过程中的特定作用需要进一步阐明.
研究的目的:
- 研究胎盘生长因子 (PlGF) 在代谢综合征 (MS) 的发展中的作用.
- 探索PlGF影响血管生成,氧化应激和脂肪组织中的胰岛素敏感性的分子机制.
- 评估PlGF在缓解MS相关病理方面的治疗潜力.
主要方法:
- 利用2型糖尿病的小鼠模型,高脂肪饮食引起的肥胖,以及老化来研究MS.
- 评估血清PlGF水平,胰岛素敏感性和脂肪组织特征.
- 在低氧条件下进行了体外实验,以检查细胞对PlGF.的反应.
- 分析了关键信号通路,包括VEGF,AMPK,PI3K/Akt和PLCγ1.1.
- 研究了plgf淘汰赛的小鼠,并用重组plgf和甲胺治疗它们.
主要成果:
- 血清PLGF水平降低与小鼠模型中的胰岛素敏感性降低和MS特征相关.
- 实验室研究表明,低PlGF会加剧氧化应激,亡,并减少缺氧下的自.
- 输出plgf的小鼠表现出MS特征,与失调的血管生成和代谢信号通路有关.
- 再组合的plgf和美特福林治疗改善了plgf淘汰的小鼠的血管生成和脂质代谢.
结论:
- PlGF在维持脂肪组织血管完整性和代谢平衡中发挥着重要作用.
- 减少的plgf通过受损的血管生成和改变的细胞信号传递,有助于MS的发展.
- PlGF代表了与年龄相关的MS和相关的代谢功能障碍的潜在治疗标.
相关概念视频
Obesity
416
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
416
Pathophysiology of Diabetes
908
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908
Inborn Errors of Metabolism
146
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
146
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K


